Pharmacokinetics of Y-4 Tablets With Pregabalin Capsules and Riluzole Tablets in Chinese Healthy Subject
Status:
RECRUITING
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
Y-4 is a new fixed-dose combination drug product containing two active ingredients of pregabalin and riluzole.
The objective of the trial is to compare pharmacokinetic characteristics of Y-4 tablets with pregabalin capsules (Lyrica) and riluzole tablets (Rilutek) in Chinese healthy adult subjects after single oral administration under fasted condition.